Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Keros Therapeutics director Jean Jacques Bienaime purchased 1,000 shares on April 15, 2026, spending $11,700 under a pre-arranged Rule 10b5-1 plan. The trade increases his direct holdings to 8,450 shares. Keros is profitable on a trailing-twelve-month basis with EPS of $2.30 and faces analyst price targets that range from $16 to $30 despite the sto…
Reddit CEO Steve Huffman sold 17,900 shares of Class A Common Stock on April 15, 2026, in a series of trades totaling about $2.85 million and exercised options to acquire 18,000 shares at $25.29. The transactions leave Huffman with indirect holdings across multiple trusts. The company’s stock is trading at $163.80, and recent analyst coverage and a…
Schrödinger, Inc. Executive Vice President and Chief Financial Officer Rachit Jain completed a disposition of 844 common shares on April 16, 2026, generating $10,758 in proceeds. The sale, executed under a pre-established Rule 10b5-1 plan, was intended to satisfy tax withholding tied to vested restricted stock units. After the transaction Jain reta…
Thomas P. Gallagher, Chairman and CEO of Miami International Holdings, Inc. (MIAX), sold 224,025 shares of common stock on April 15, 2026, generating roughly $9.7 million in proceeds after executing multiple trades at prices between $42.57 and $44.41. On the same day he exercised options to buy 70,001 shares at $12 per share through Gallagher Inves…
Ou June, a 10% owner of Figure Technology Solutions (FIGR), disposed of 67,840 shares of Class A common stock on April 15, 2026, for $2,387,554 in multiple trades executed under a Rule 10b5-1 plan. The director also converted an equal number of Class B shares into Class A on the same day. FIGR reported strong loan marketplace growth in Q1 2026 but …
Terry D. McAllister, a director at Primoris Services Corp (NASDAQ: PRIM), acquired 10.144 shares of common stock on April 15, 2026, through the broker-sponsored dividend reinvestment plan, at $164.404 per share for a total of $1,667. The trade leaves him with 20,856.554 directly held shares and an additional indirect holding of 10,000 shares via a …
Figure Technology Solutions director Michael Scott Cagney sold 67,840 shares of Class A common stock on April 15, 2026, raising roughly $2.38 million through multiple transactions under a Rule 10b5-1 plan. The same day he converted an equal number of Class B shares into Class A shares. The company posted robust loan marketplace growth in Q1 2026 bu…
Ouster Chief Technology Officer Mark Frichtl sold 30,000 shares of common stock on April 17, 2026, receiving $754,395 in proceeds at a weighted average price of $25.1465 and, on the same day, exercised 30,000 stock options at $2.13. The transaction was executed under a Rule 10b5-1 trading plan dated December 15, 2025. The company recently reported …
SmartStop Self Storage REIT director David J. Mueller sold 425 shares on April 16, 2026, under a Rule 10b5-1 plan. The transaction and subsequent holdings are detailed alongside the REIT's recent quarterly results, a $100 million credit joint venture, and analyst commentary on valuation and operational trends.
Nick Lane, President of Equitable Financial at Equitable Holdings Inc (EQH), sold 10,000 shares on April 15, 2026, for $404,421 and exercised options to acquire 10,000 shares at $23.18 per share the same day. The moves occurred as the stock rose about 11.5% over the prior week and now trades at $41.73. Lane’s direct holdings total 124,218.2658 shar…
Silver Lake Partners IV, a roughly ten percent stakeholder in Dell Technologies Inc (NASDAQ:DELL), sold 375,900 shares of Class C common stock on April 16, 2026. The transactions generated about $67.5 million in proceeds and coincided with Dell trading close to its 52-week high. The move included conversions of Class B shares into Class C shares am…
Jeffrey T. Taylor, Executive Vice President at Velocity Financial, sold 2,130 shares on April 17, 2026, at a weighted average price of $20.00 for proceeds of $42,600. The sale leaves Taylor with 178,985 shares directly held. The transaction occurs as Velocity Financial's stock trades near $19.90 and following a fourth-quarter fiscal 2025 report tha…
Daniel A. Simkowitz, co-president of Morgan Stanley, sold 14,690 shares of the bank's common stock on April 17, 2026, realizing about $2.78 million. The sale occurred as the stock traded close to its 52-week high following a 77.6% year-over-year gain and came after the firm reported stronger-than-expected first-quarter results that prompted several…
International Seaways Senior Vice President and CFO Jeffrey Pribor sold 1,000 shares of company stock on April 15, 2026, under a pre-arranged trading plan. The transaction was executed at $74.50 per share, totaling $74,500. The company recently reported robust fourth-quarter 2025 results, prompting a price-target increase from BTIG and the declarat…
Whitehawk Therapeutics CFO Scott M. Giacobello sold 218,600 shares in two broker-assisted transactions on April 15-16, 2026, raising $882,028 to satisfy tax-withholding on vested restricted stock units. After the sales he holds 295,224 shares. The company recently reported MUC16 expression data at the SGO 2026 meeting and attracted a Market Outperf…
Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals, purchased 1,369 shares on April 15, 2026, for $2.97 per share, a $4,065 transaction. The stock currently trades at $3.10, up roughly 12% over the past week but still down 59% over six months. An analysis cited in the filing notes a price target of $25, suggesting the compan…
Ryan Cohlhepp, President and COO of Bicara Therapeutics Inc (NASDAQ: BCAX), sold 12,500 shares on April 15, 2026, for $287,591 and concurrently exercised options to acquire 8,000 shares. The transactions occurred under a Rule 10b5-1 plan and come as BCAX trades close to its 52-week high following strong year-over-year gains and recent clinical and …
Processa Pharmaceuticals' Chief Administrative Officer, Wendy Guy, purchased 1,583 shares of the company's common stock on April 15, 2026, at $2.97 per share, a transaction totaling $4,701. After the trade Guy directly holds 4,693 shares and indirectly holds 333 shares through CorLyst, LLC. The stock is trading at $3.10, up 11.91% over the past wee…
International Seaways President and CEO Lois K. Zabrocky sold 2,000 shares of the company's common stock on April 15, 2026, for roughly $149,143 under a Rule 10b5-1 plan. The sale occurred as INSW shares were trading close to a 52-week peak after the company reported strong fourth-quarter 2025 earnings, a record dividend and a bullish response from…
Processa Pharmaceuticals (PCSA) Chief Executive Officer George K. Ng purchased 1,843 shares on April 15, 2026 at $2.97 per share, a transaction totaling about $5,473. The purchase increases Ng's direct holdings to 5,492 shares and follows a recent short-term rise in the stock, which is trading at $3.10 and has gained nearly 12% over the last week. …
Grace Wong-Sarad, Principal Accounting Officer at Alector, Inc. (NASDAQ: ALEC), sold 1,820 shares on April 16, 2026, for $2.65 per share, a transaction valued at $4,823. The sale was made under a Rule 10b5-1 trading plan adopted on September 5, 2025. The stock is trading at $2.57, below InvestingPro's Fair Value estimate, even after a 177% gain ove…
Lauren Freemen-Bosworth, Executive Vice President at Pitney Bowes Inc. (PBI), sold 2,038 shares of company stock on April 16-17, 2026, receiving $25,185 in aggregate. The disposals were part of a pre-arranged Rule 10b5-1 plan adopted October 31, 2025. The sales occurred as the stock trades near its 52-week high and follow quarterly results that bea…
Dennis Polk, a member of TD Synnex's board and chair of Hyve Solutions, sold 2,500 shares of TD Synnex (SNX) on April 17, 2026, for $210.7 per share, totaling $526,750. The disposal was made under a Rule 10b5-1 trading plan adopted by the Polk Family Trust on January 16, 2026. Polk retains direct ownership of 22,439 shares and indirect ownership of…
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) Co-Global CEO Matthias Aydt purchased one share of the company's Series A Preferred Stock for $100 on April 15, 2026, according to an SEC Form 4. The move is notable for its symbolic value as the electric vehicle maker works to transition from strategic planning to early commercialization whil…
Martine Rothblatt, chairperson and CEO of United Therapeutics Corp (NASDAQ: UTHR), sold $5.48 million of company stock on April 16, 2026, in multiple transactions at prices between $573.9595 and $581.3325. On the same day she exercised options to acquire 9,500 shares at $146.03 per share. The trades were carried out under a 10b5-1 plan adopted Nove…
